Grant: Idea to Innovation
McGill University
$155,000.00
Point of need biosensor on a semiconductor imaging chip
EF 2023-24
Résumé
Point-of-need (PON) biosensors are important tools towards the democratization of access to health care and removal of health disparities. In our lab we developed, demonstrated, and patented a novel biosensor that uses electrochemiluminescence on a semiconductor image sensor to detect analytes of interest. This device can measure uric acid levels in saliva and urine in the physiological range and can be adapted for use with other analytes of interest. Measurement of uric acid levels in the blood is recommended for diagnosis, monitoring, and to adjust urate-lowering therapy. Currently, uric acid measurements require access to a laboratory, a venopuncture and a subsequent consultation to review the test results. To streamline these steps, we developed a non-invasive biosensor for uric acid measurement that can be used in the clinic or as a home test kit. The objectives of this proposal are: (1) improve the limit of detection of the device, extend the linear range of operation, and test the ability to multiplex; (2) test and validate the use of the device for monitoring of uric acid in saliva or serum of patients diagnosed with gout outside the PI's laboratory, determine the sensitivity and specificity of the device; (3) design and fabricate a device for use at the point-of-care, with a business case in mind.
Programme
Idea to Innovation
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
586897-2023
Name nom
Wachsmann-Hogiu, Sebastian S
Department département
Bioengineering
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2023
Award amount
155000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Bioanalytical chemistry
Research subject en
Chimie analytique
Research subject fr
Chimie bioanalytique
Application title
Point of need biosensor on a semiconductor imaging chip
Keyword
biosensors; CMOS chips; electrochemiluminescence; gout; rheumatology; semiconductor optical detectors
Application summary
Point-of-need (PON) biosensors are important tools towards the democratization of access to health care and removal of health disparities. In our lab we developed, demonstrated, and patented a novel biosensor that uses electrochemiluminescence on a semiconductor image sensor to detect analytes of interest. This device can measure uric acid levels in saliva and urine in the physiological range and can be adapted for use with other analytes of interest. Measurement of uric acid levels in the blood is recommended for diagnosis, monitoring, and to adjust urate-lowering therapy. Currently, uric acid measurements require access to a laboratory, a venopuncture and a subsequent consultation to review the test results. To streamline these steps, we developed a non-invasive biosensor for uric acid measurement that can be used in the clinic or as a home test kit. The objectives of this proposal are: (1) improve the limit of detection of the device, extend the linear range of operation, and test the ability to multiplex; (2) test and validate the use of the device for monitoring of uric acid in saliva or serum of patients diagnosed with gout outside the PI's laboratory, determine the sensitivity and specificity of the device; (3) design and fabricate a device for use at the point-of-care, with a business case in mind.